Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: David J. Cohen

October 31, 2017

REGISTER for free or LOG IN to view this content

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presentation

TCT 2017

Aortic Valve

Up Next

Presentation TCT 2017

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Renal Stenting

Presenter: Mark C. Bates

October 31, 2017

More slides +

Presentation TCT 2017

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Additional Medical Management

Presenter: Christopher J. Cooper

October 31, 2017

Presentation TCT 2017

Outpatient Same Day PCI and CRM Procedures

Presenter: Jeffrey G. Carr

October 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.